0001493152-20-003043.txt : 20200226
0001493152-20-003043.hdr.sgml : 20200226
20200226203216
ACCESSION NUMBER: 0001493152-20-003043
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200221
FILED AS OF DATE: 20200226
DATE AS OF CHANGE: 20200226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Stein Robert Benjamin
CENTRAL INDEX KEY: 0001597158
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51353
FILM NUMBER: 20658031
MAIL ADDRESS:
STREET 1: C/O AGENUS INC.
STREET 2: 3 FORBES ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protagenic Therapeutics, Inc.\new
CENTRAL INDEX KEY: 0001022899
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 061390025
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 FIFTH AVENUE
STREET 2: SUITE 500
CITY: NEW YORK
STATE: NY
ZIP: 10010
BUSINESS PHONE: (212) 994-8200
MAIL ADDRESS:
STREET 1: 149 FIFTH AVENUE
STREET 2: SUITE 500
CITY: NEW YORK
STATE: NY
ZIP: 10010
FORMER COMPANY:
FORMER CONFORMED NAME: Atrinsic, Inc.
DATE OF NAME CHANGE: 20090630
FORMER COMPANY:
FORMER CONFORMED NAME: NEW MOTION, INC.
DATE OF NAME CHANGE: 20070504
FORMER COMPANY:
FORMER CONFORMED NAME: MPLC, Inc.
DATE OF NAME CHANGE: 20050608
4
1
ownership.xml
X0306
4
2020-02-21
0
0001022899
Protagenic Therapeutics, Inc.\new
PTIX
0001597158
Stein Robert Benjamin
149 FIFTH AVE, SUITE 500
NEW YORK
NY
10010
1
0
0
0
PTIX Common stock Options
1.75
2020-02-21
4
A
0
150000
A
2021-02-21
2030-02-21
PTIX Common Stock, Par Value $0.0001
150000
150000
D
As this was an option grant, there was no cost to the recipient.
The options vest monthly over 12 months, beginning upon the date of grant.
/s/ Robert Stein
2020-02-26